Canada markets closed

Propanc Biopharma, Inc. (PPCB)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00080.0000 (0.00%)
At close: 03:03PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-06-30
2022-06-30
2021-06-30
2020-06-30
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
201.98
247.919
256.052
230.956
179.987
Selling General and Administrative
1,249
1,529
1,735
1,581
3,314
Total Operating Expenses
1,451
1,777
1,991
1,812
3,494
Operating Income or Loss
-1,451
-1,777
-1,991
-1,812
-3,494
Interest Expense
714.146
532.821
568.798
449.457
1,748
Total Other Income/Expenses Net
-457.053
-480.977
-159.009
122.237
366.244
Income Before Tax
-2,622
-2,790
-2,713
-2,139
-4,875
Income Tax Expense
-129.14
-129.841
-54.977
-113.415
-134.728
Income from Continuing Operations
-2,493
-2,661
-2,658
-2,026
-4,741
Net Income
-2,493
-2,661
-2,658
-2,026
-4,741
Net Income available to common shareholders
-2,728
-3,127
-3,358
-2,418
-4,741
Basic EPS
0.29
-1.80
-49.23
-800.00
-18.37k
Diluted EPS
0.29
-1.80
-49.23
-800.00
-18.37k
Basic Average Shares
4,368
1,739
68.219
3.032
0.258
Diluted Average Shares
4,368
1,739
68.219
3.032
0.258